pharmacology/neuroleptic malignant syndrome

See Explanation

[]

Question 1 / 9
683d1311c1b3f4bd827da92e

Psychiatry

pharmacology

neuroleptic malignant syndrome

A 42-year-old woman, recently admitted to an inpatient psychiatric unit for acute symptom exacerbation of her bipolar I disorder with psychotic features, presents with a constellation of concerning signs. Over the past 24 hours, nurses note increasing somnolence followed by pronounced agitation and fluctuating levels of consciousness. She has been receiving an antipsychotic medication, with a dose adjustment initiated 3 days prior. Her medical history includes well-controlled hypertension and type 2 diabetes. On examination, her temperature is 39.5 °C, pulse is 125 beats/min, respiratory rate is 26 breaths/min, and blood pressure is 155/95 mm Hg. Neurological assessment reveals generalized lead-pipe muscle rigidity and a diminished pupillary light reflex. What is the most likely diagnosis and the critical initial intervention required?

Lab ParameterValueReference Range
White Blood Cell Count18.0 x 10^9/L4.0-11.0 x 10^9/L
Serum Creatine Kinase1200 U/L<200 U/L
Sodium138 mmol/L135-145 mmol/L
Potassium5.2 mmol/L3.5-5.0 mmol/L
Creatinine120 µmol/L45-90 µmol/L
Blood Urea Nitrogen9.5 mmol/L2.5-7.1 mmol/L

Edit question